linkedin Voxel S.A.
Facebook Voxel S.A.
Strona główna > Dla Pacjenta > Kontakt

Oncology package

Cooperation

Rapid Cancer Treatment

VOXEL S.A. warmly invites healthcare providers carrying out diagnostic tests as part of the Rapid Oncology Therapy programme to collaborate with us.

We offer tests using the following method:

TK

computed tomography

MR

magnetic resonance imaging

PET-TK

positron emission tomography

SPECT

single-photon emission tomography

We guarantee:

A qualified and experienced medical team

High-quality specialist medical equipment

Timeliness and comprehensiveness of services

Short turnaround time
for the tests, including a description

DILO Card

Free PET/CT scans

A healthcare provider who has carried out in-depth oncological diagnostics on the basis of an oncological diagnosis and treatment chart may claim reimbursement for this using the in-depth diagnostics package and aggregation products, in accordance with the rules set out in Annex 5c to Order No. 182/ 2019/DSOZ on the determination of the conditions for concluding and performing contracts for the provision of healthcare services in the category of specialist outpatient care.

Products for summation in the field of oncological diagnostics

Code Product name to be totalled Point value Comments
5.31.00.0000022 Z22 Treatment services – group 22 1924
  • in accordance with the current guidelines for specialist outpatient services
  • to be demonstrated only with the appropriate preliminary or in-depth diagnostic package
5.10.00.0000103 positron emission tomography (PET) using Group I radiopharmaceuticals 2795
  • per test
  • Group I comprises radiopharmaceuticals: 18F-FDG, 18F-NaF
  • to be covered only with the appropriate in-depth diagnostic package, excluding lung cancer diagnostics (Chest Package), where it is covered with either the initial or in-depth diagnostic package
5.10.00.0000104 Positron emission tomography (PET) using Group II radiopharmaceuticals 4142
  • per test
  • Group II comprises other radiopharmaceuticals: 18F-choline (18-fluorocholine), which is authorised in Poland, or those not authorised in Poland but imported under the end-use import scheme or produced for the healthcare provider’s own use by their laboratory in accordance with the Atomic Energy Act
  • to be covered only with the appropriate in-depth diagnostic package, with the exception of lung cancer diagnostics (Chest Package), where it is covered with either the initial or in-depth diagnostic package

This means that a patient with a DILO card may, for example, be referred for a PET scan as part of an in-depth diagnostic process, which the healthcare provider will settle directly under their contract with the National Health Fund (NFZ). A healthcare provider that does not have a PET/CT facility within its own organisation may commission a PET scan from an external provider on the basis of a contract. We invite both healthcare organisations and doctors to get in touch.

For further information, please contact the Medical Department at VOXEL S.A.

Contact

We look forward to working with you

umowy@voxel.pl
12 359 98 10